Détail - canceropole-wordpress

Evolution of myocardial steatosis in high cardiovascular risk T2DM patients treated by GLP1 receptor agonists: LICAS study.

Houbachi L, Walker PM, Fournel I, Ksiazek E, Petit JM, Cochet A, Leclercq T, Roger A, Simoneau I, Bouillet B, Guenancia C

Diabetes Res Clin Pract. 2025 02 1;:112017

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

Caussy C, Vergès B, Leleu D, Duvillard L, Subtil F, Abichou-Klich A, Hervieu V, Milot L, Ségrestin B, Bin S, Rouland A, Delaunay D, Morcel P, Hadjadj S, Primot C, Petit JM, Charrière S, Moulin P, Levrero M, Cariou B, Disse E

Diabetes Care. 2025 01 31;:

Update on Neoadjuvant and Adjuvant BRAF Inhibitors in Papillary Craniopharyngioma: A Systematic Review.

Cossu G, Ramsay DSC, Daniel RT, El Cadhi A, Kerherve L, Morlaix E, Houidi SA, Millot-Piccoli C, Chapon R, Le Van T, Cao C, Farah W, Lleu M, Baland O, Beaurain J, Petit JM, Lemogne B, Messerer M, Berhouma M

Cancers (Basel). 2024 10 14;16(20):

Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes.

Denimal D, Duvillard L, Béland-Bonenfant S, Terriat B, Pais-de-Barros JP, Simoneau I, Rouland A, Houbachi L, Bouillet B, Vergès B, Petit JM

Diabetes Metab. 2024 05 4;:101542

No effect of liraglutide on high density lipoprotein apolipoprotein AI kinetics in patients with type 2 diabetes.

Duvillard L, de Barros JP, Rouland A, Simoneau I, Denimal D, Bouillet B, Petit JM, Vergès B

Diabetes Metab. 2024 04 21;:101535

Screening and management of metabolic complications of mTOR inhibitors in real-life settings.

Spanjaard P, Petit JM, Schmitt A, Vergès B, Bouillet B

Ann Endocrinol (Paris). 2023 12 1;:

Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes.

Denimal D, Béland-Bonenfant S, Pais-de-Barros JP, Rouland A, Bouillet B, Duvillard L, Vergès B, Petit JM

Cardiovasc Diabetol. 2023 11 8;22(1):310

Inflammation and oxidative stress markers in type 2 diabetes patients with Advanced Carotid atherosclerosis.

Ménégaut L, Laubriet A, Crespy V, Leleu D, Pilot T, Van Dongen K, de Barros JP, Gautier T, Petit JM, Thomas C, Nguyen M, Steinmetz E, Masson D

Cardiovasc Diabetol. 2023 09 14;22(1):248

Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial.

Paris J, Legris P, Devaux M, Bost S, Gueneau P, Rossi C, Manfredi S, Bouillet B, Petit JM, Pistre P, Boulin M

Cancers (Basel). 2023 09 13;15(18):

Case Report: Giant insulinoma, a very rare tumor causing hypoglycemia.

Tarris G, Rouland A, Guillen K, Loffroy R, Lariotte AC, Rat P, Bouillet B, Andrianiaina H, Petit JM, Martin L

Front Endocrinol (Lausanne). 2023 05 10;14:1125772

Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes.

Denimal D, Bergas V, Pais-de-Barros JP, Simoneau I, Demizieux L, Passilly-Degrace P, Bouillet B, Petit JM, Rouland A, Bataille A, Duvillard L, Vergès B

Cardiovasc Diabetol. 2023 05 4;22(1):104

Heterozygous pathogenic variants in POMC are not responsible for monogenic obesity: implication for MC4R agonist use.

Le Collen L, Delemer B, Poitou C, Vaxillaire M, Toussaint B, Dechaume A, Badreddine A, Boissel M, Derhourhi M, Clément K, Petit JM, Mau-Them FT, Bruel AL, Thauvin-Robinet C, Saveanu A, Cherifi BG, Le Beyec-Le Bihan J, Froguel P, Bonnefond A

Genet Med. 2023 04 20;:100857

Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study).

Nabi O, Lapidus N, Boursier J, de Ledinghen V, Petit JM, Kab S, Renuy A, Zins M, Lacombe K, Serfaty L

Hepatology. 2023 02 24;:

Concise review of lipidomics in nonalcoholic fatty liver disease.

Béland-Bonenfant S, Rouland A, Petit JM, Vergès B

Diabetes Metab. 2023 02 11;:101432

Incidence of new-onset type 1 diabetes during Covid-19 pandemic: A French nationwide population-based study.

Mariet AS, Petit JM, Benzenine E, Quantin C, Bouillet B

Diabetes Metab. 2023 01 17;:101425

Glycemic control in people with diabetes treated with cancer chemotherapy: contribution of continuous glucose monitoring.

Legris P, Bouillet B, Pâris J, Pistre P, Devaux M, Bost S, Simoneau I, Manfredi S, Drouillard A, Bastie JN, Chaix M, Massoud P, Rouland A, Aho S, Boulin M, Petit JM

Acta Diabetol. 2023 01 13;:

Hospitalizations for Anorexia Nervosa during the COVID-19 Pandemic in France: A Nationwide Population-Based Study.

Chauvet-Gelinier JC, Roussot A, Vergès B, Petit JM, Jollant F, Quantin C

J Clin Med. 2022 08 16;11(16):

Profiling of lipid mediators in atherosclerotic carotid plaques from type 2 diabetic and non-diabetic patients.

Ménégaut L, Laubriet A, Crespy V, Nguyen M, Petit JM, Tarris G, Pilot T, Varin A, Choubley H, Bergas V, de Barros JP, Thomas C, Steinmetz E, Masson D

Prostaglandins Leukot Essent Fatty Acids. 2022 08 4;184:102477

Healing of diabetic foot ulcers is independently associated with the use of angiotensin receptor blockers but not with those of diuretics and angiotensin conversion enzyme inhibitors.

Lapray M, Petit JM, Fourmont C, Rouland A, Vergès B, Bouillet B

Diabetes Metab. 2022 Mar 1;:101336

The Burden of NAFLD in Type 2 Diabetic Subjects from the General Population: a Nationwide Population-Based Follow-Up Study (NASHCO).

Nabi O, Boursier J, Lapidus N, Mathurin P, de Ledinghen V, Petit JM, Goldberg M, Zins M, Lacombe K, Serfaty L

Liver Int. 2022 Jan 23;:

Self-harm hospitalization following bariatric surgery in adolescents and young adults.

Goueslard K, Jollant F, Petit JM, Quantin C

Clin Nutr. 2021 Dec 5;41(1):238-245

Characteristics of new patient referrals to specialised diabetic foot units across Europe and factors influencing delays.

Bouillet B, Ahluwalia R, Iacopi E, Garcia-Klepzig JL, Lüdemann C, Manu C, Meloni M, Saenz De Buruaga VR, Vouillarmet J, Petit JM, Van Acker K, Lázaro-Martínez JL

J Wound Care. 2021 Oct 2;30(10):804-808

Liraglutide reduces plasma PCSK9 in patients with type 2 diabetes not treated with statins.

Vergès B, Hassid J, Rouland A, Bouillet B, Simoneau I, Petit JM, Duvillard L

Diabetes Metab. 2021 Sep 19;:101284

Adrenal insufficiency revealing a bilateral adrenal hemorrhage-adrenal infarction related to antiphospholipid syndrome.

Billet AC, Chevallier O, Samsom M, Petit JM, Bonnotte B, Audia S

Am J Med. 2021 Sep 9;:

Management of diabetes mellitus in patients with cirrhosis: an overview and joint statement.

Boursier J, Anty R, Carette C, Cariou B, Castera L, Caussy C, Fontaine H, Garioud A, Gourdy P, Guerci B, Guillaume M, Michot N, Minello A, Ouizeman DJ, Serfaty L, Bonnet F, Vergès B, Petit JM,

Diabetes Metab. 2021 Aug 4;:101272

Frequent and severe hypoglycaemia detected with continuous glucose monitoring in older institutionalised patients with diabetes.

Bouillet B, Tscherter P, Vaillard L, Nonciaux C, Hourdain P, Ravier A, Rouland A, Petit JM, Vergès B, Quilot E

Age Ageing. 2021 Jul 27;:

Impact of the COVID-19 Epidemic on hospitalization for diabetic foot ulcers during lockdown: A French nationwide population-based study.

Mariet AS, Benzenine E, Bouillet B, Vergès B, Quantin C, Petit JM

Diabet Med. 2021 Apr 2;:e14577

Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer.

Vergès B, Brands R, Fourmont C, Petit JM, Simoneau I, Rouland A, Legris P, Bouillet B, Chauvet-Gélinier JC

Diabetes Metab. 2021 Mar 12;:101245

Glycemic Variability Assessment with a 14-Day Continuous Glucose Monitoring System: When and How Long to Measure MAGE (Mean Amplitude of Glucose Excursion) for Optimal Reliability?

Vergès B, Pignol E, Rouland A, Bouillet B, Baillot-Rudoni S, Quilot E, Djeffal A, Petit JM

J Diabetes Sci Technol. 2021 Feb 10;:1932296821992060

Liraglutide Increases the Catabolism of Apolipoprotein B100-Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression.

Vergès B, Duvillard L, Pais de Barros JP, Bouillet B, Baillot-Rudoni S, Rouland A, Petit JM, Degrace P, Demizieux L

Diabetes Care. 2021 Feb 2;:

Diabetes is not associated with COVID-19-related mortality in older institutionalized people.

Legris P, Vaillard L, Nonciaux C, Hourdain P, Taroux M, Petit JM, Vergès B, Bouillet B

Diabetes Metab. 2021 Jan 27;:101235

Increased Risk of Hospitalization for Pancreatic Cancer in the First 8 Years after a Gestational Diabetes Mellitus regardless of Subsequent Type 2 Diabetes: A Nationwide Population-Based Study.

Simon J, Goueslard K, Arveux P, Bechraoui-Quantin S, Petit JM, Quantin C

Cancers (Basel). 2021 Jan 15;13(2):

Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion.

Rouland A, Bouillet B, Legris P, Simoneau I, Petit JM, Vergès B

Clin Pharmacol. 2021 ;13:33-37

Fatty acid composition of the erythrocyte membrane and risk of hepatocellular carcinoma in cirrhotic patients.

Mouillot T, Rizk M, Pais de Barros JP, Gilloteau A, Busson A, Bernard-Chabert B, Thiefin G, Barraud H, Bronowicki JP, Richou C, Di Martino V, Doffoel M, Minello A, Latournerie M, Jouve JL, Brondel L, Brindisi MC, Petit JM, Hillon P, Cottet V,

Aliment. Pharmacol. Ther.. 2020 Aug 11;:

Increased body fat mass reduces the association between fructosamine and HbA1c in obese type 2 diabetic patients.

Vergès B, Rouland A, Baillot-Rudoni S, Brindisi MC, Duvillard L, Simoneau I, Legris P, Petit JM, Bouillet B

J Diabetes Investig. 2020 Aug 7;:

Association between hospital admission for ketoacidosis and subsequent suicide attempt in young adults with type 1 diabetes.

Petit JM, Goueslard K, Chauvet-Gelinier JC, Bouillet B, Vergès B, Jollant F, Quantin C

Diabetologia. 2020 Jul 8;:

Clinical Spectrum of Primary Adrenal Lymphoma: Results of a Multicenter Cohort Study.

Majidi F, Martino S, Kondakci M, Antke C, Haase M, Chortis V, Arlt W, Ronchi CL, Fassnacht M, Laurent C, Petit JM, Casanovas O, Habra M, Kanji A, Salvatori R, Ho ATN, Spyroglou A, Beuschlein F, Villa D, Limvorapitak W, Wahlin BE, Gimm O, Rudelius M, Schott M, Germing U, Haas R, Gattermann N

Eur. J. Endocrinol.. 2020 Jun 1;:

Are older patients with diabetes still being overtreated in French long-term care homes?

Quilot E, Petit JM, Vergès B, Bouillet B

Age Ageing. 2020 May 26;:

Whole-exome sequencing identifies the first French MODY 6 family with a new mutation in the NEUROD1 gene.

Bouillet B, Crevisy E, Baillot-Rudoni S, Gallegarine D, Jouan T, Duffourd Y, Petit JM, Vergès B, Callier P

Diabetes Metab.. 2020 Mar 14;:

[Thyroiditis: What's new in 2019?]

Rouland A, Buffier P, Petit JM, Vergès B, Bouillet B

Rev Med Interne. 2020 Feb 24;:

Personality types in individuals with type 1 and type 2 diabetes.

Rouland A, Chauvet-Gelinier JC, Sberna AL, Crevisy E, Buffier P, Mouillot T, Petit JM, Verges B

Endocr Connect. 2020 Feb 1;:

[Who is at risk for drug-drug interactions in type 2 diabetic patients?]

Laurent C, Aho Glele LS, Lazzarotti A, Petit JM, Vergès B, Bouillet B

Presse Med. 2019 Nov 21;:

A low-carbohydrate high-fat diet initiated promptly after diagnosis provides clinical remission in three patients with type 1 diabetes.

Bouillet B, Rouland A, Petit JM, Vergès B

Diabetes Metab.. 2019 Jul 10;:

Plasma apolipoprotein C1 concentration is associated with plasma triglyceride concentration but not with visceral fat and liver fat content in people with type 1 diabetes.

Bouillet B, Gautier T, Rouland A, Duvillard L, Petit JM, Lagrost L, Vergès B

Acta Diabetol. 2019 May 22;:

CETP activity is not associated with carotid intima-media thickness in patients with poorly controlled type 2 diabetes.

Bouillet B, Gautier T, Terriat B, Lagrost L, Verges B, Petit JM

Acta Diabetol. 2019 Apr 12;:

Depression and obesity, data from a national administrative database study: Geographic evidence for an epidemiological overlap.

Chauvet-Gelinier JC, Roussot A, Cottenet J, Brindisi MC, Petit JM, Bonin B, Vergès B, Quantin C

PLoS ONE. 2019 ;14(1):e0210507

Type A competitiveness traits correlate with downregulation of c-Fos expression in patients with type 1 diabetes.

Chauvet-Gélinier JC, Mosca-Boidron AL, Lemogne C, Ragot S, Forestier N, Callegarin D, Allard C, Rebaï A, Bouillet B, Ponavoy E, Simoneau I, Petit JM, Bondolfi G, Callier P, Trojak B, Bonin B, Vergès B

Diabetes Metab.. 2018 Nov 23;:

Malnutrition in type 2 diabetic patients does not affect healing of foot ulcers.

Rouland A, Fourmont C, Sberna AL, Aho Glele LS, Mouillot T, Simoneau I, Vergès B, Petit JM, Bouillet B

Acta Diabetol. 2018 Oct 3;:

Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population.

Wargny M, Ducluzeau PH, Petit JM, Le May C, Smati S, Arnaud L, Pichelin M, Bouillet B, Lannes A, Blanchet O, Lefebvre P, Francque S, Van Gaal L, Staels B, Vergès B, Boursier J, Cariou B

Atherosclerosis. 2018 Sep 13;278:82-90

Increased Risk of Rehospitalization for Acute Diabetes Complications and Suicide Attempts in Patients With Type 1 Diabetes and Comorbid Schizophrenia.

Goueslard K, Petit JM, Cottenet J, Chauvet-Gelinier JC, Jollant F, Quantin C

Diabetes Care. 2018 Aug 27;:

Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus.

Vergès B, Duvillard L, Pais de Barros JP, Bouillet B, Baillot-Rudoni S, Rouland A, Sberna AL, Petit JM, Degrace P, Demizieux L

Arterioscler. Thromb. Vasc. Biol.. 2018 Jul 19;:

Unexpected adverse effect of metyrapone: a case report.

Rouland A, Nguyen A, Fourmont C, Lapray M, Vergès B, Petit JM, Bouillet B

Clin. Endocrinol. (Oxf). 2018 Apr 19;:

Liver Fat Content in People with Pituitary Diseases: Influence of Serum IGF1 Levels.

Nguyen A, Ricolfi F, Lemogne B, Aho S, Lemaire S, Bouillet B, Duvillard L, Denimal D, Fourmont C, Loffroy R, Cercueil JP, Verges B, Petit JM

Horm. Metab. Res.. 2018 Apr;50(4):303-307

Application of the new eLIFT test for the non-invasive diagnosis of advanced liver fibrosis in people with type 2 diabetes.

Petit JM, Bouillet B, Loffroy R, Rouland A, Hillon P, Verges B

J. Hepatol.. 2018 Mar;68(3):603-604

European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver diseas

Sberna AL, Bouillet B, Rouland A, Brindisi MC, Nguyen A, Mouillot T, Duvillard L, Denimal D, Loffroy R, Vergès B, Hillon P, Petit JM

Diabet. Med.. 2018 Mar;35(3):368-375

Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial.

Edmonds M, Lázaro-Martínez JL, Alfayate-García JM, Martini J, Petit JM, Rayman G, Lobmann R, Uccioli L, Sauvadet A, Bohbot S, Kerihuel JC, Piaggesi A

Lancet Diabetes Endocrinol. 2018 03;6(3):186-196

Uptake in the pancreatic uncinate process on the 111In-octreotide scintigraphy: How to distinguish physiological from pathological uptake?

Ait Boudaoud A, Verges B, Petit JM, Tatulashvili S, Cochet A, Humbert O

Nucl Med Commun. 2017 Jul;:

Early screening for type 2 diabetes following gestational diabetes mellitus in France: hardly any impact of the 2010 guidelines.

Goueslard K, Cottenet J, Mariet AS, Sagot P, Petit JM, Quantin C

Acta Diabetol. 2017 Apr;:

GLP-1 receptor agonists in NAFLD.

Petit JM, Vergès B

Diabetes Metab.. 2017 Apr;43 Suppl 1:2S28-2S33

Type A personality is not associated with poor glycaemic control: Data from cross-sectional and longitudinal surveys of people with type 1 or type 2 diabetes.

Chauvet-Gélinier JC, Trojak B, Lemogne C, Louprou A, Bouillet B, Simoneau I, Chahraoui K, Petit JM, Consoli SM, Bonin B, Vergès B

Diabetes Metab.. 2017 Apr;43(2):176-179

Glycaemic control influences the relationship between plasma PCSK9 and LDL cholesterol in type 1 diabetes.

Laugier-Robiolle S, Vergès B, Le Bras M, Gand E, Bouillet B, Saulnier PJ, Le May C, Pichelin M, Maréchaud R, Petit JM, Hadjadj S, Cariou B

Diabetes Obes Metab. 2017 Mar;19(3):448-451

Impairment of the Ability of HDL From Patients With Metabolic Syndrome but Without Diabetes Mellitus to Activate eNOS: Correction by S1P Enrichment.

Denimal D, Monier S, Brindisi MC, Petit JM, Bouillet B, Nguyen A, Demizieux L, Simoneau I, Pais de Barros JP, Vergès B, Duvillard L

Arterioscler. Thromb. Vasc. Biol.. 2017 Mar;:

Effect of Liraglutide Therapy on Liver Fat Content in Patients With Inadequately Controlled Type 2 Diabetes: The Lira-NAFLD Study.

Petit JM, Cercueil JP, Loffroy R, Denimal D, Bouillet B, Fourmont C, Chevallier O, Duvillard L, Vergès B

J. Clin. Endocrinol. Metab.. 2017 Feb;102(2):407-415

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly.

Potorac I, Petrossians P, Daly AF, Alexopoulou O, Borot S, Sahnoun-Fathallah M, Castinetti F, Devuyst F, Jaffrain-Rea ML, Briet C, Luca F, Lapoirie M, Zoicas F, Simoneau I, Diallo AM, Muhammad A, Kelestimur F, Nazzari E, Centeno RG, Webb SM, Nunes ML, Hana V, Pascal-Vigneron V, Ilovayskaya I, Nasybullina F, Achir S, Ferone D, Neggers SJ, Delemer B, Petit JM, Schöfl C, Raverot G, Goichot B, Rodien P, Corvilain B, Brue T, Schillo F, Tshibanda L, Maiter D, Bonneville JF, Beckers A

Endocr. Relat. Cancer. 2016 Nov;23(11):871-881

Adrenal lymphoma: presentation, management and prognosis.

Laurent C, Casasnovas O, Martin L, Chauchet A, Ghesquieres H, Aussedat G, Fornecker LM, Bologna S, Borot S, Laurent K, Bouillet B, Verges B, Petit JM

QJM. 2016 Oct;:

Plasma apolipoprotein C1 concentration is associated with plasma triglyceride concentration, but not visceral fat, in patients with type 2 diabetes.

Bouillet B, Gautier T, Aho LS, Duvillard L, Petit JM, Lagrost L, Vergès B

Diabetes Metab.. 2016 Sep;42(4):263-6

Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.

Ménégaut L, Masson D, Abello N, Denimal D, Truntzer C, Ducoroy P, Lagrost L, Pais de Barros JP, Athias A, Petit JM, Martin L, Steinmetz E, Kretz B

Atherosclerosis. 2016 Aug;251:339-47

Potential influence of Type A personality on plasma C-reactive protein levels in people with diabetes.

Chauvet-Gélinier JC, Trojak B, Lemogne C, Aho-Glélé LS, Brindisi MC, Bouillet B, Ponavoy E, Meille V, Simoneau I, Chahraoui K, Vaillant G, Petit JM, Consoli SM, Bonin B, Vergès B

Diabetes Metab.. 2016 Apr;42(2):88-95

Major changes in the sphingophospholipidome of HDL in non-diabetic patients with metabolic syndrome.

Denimal D, Nguyen A, Pais de Barros JP, Bouillet B, Petit JM, Vergès B, Duvillard L

Atherosclerosis. 2016 Mar;246:106-14

Improvement of liver function tests by antidiabetic agents: The need for multidirectional analysis.

Vergès B, Petit JM, Bouillet B

Diabetes Metab.. 2016 Feb;42(1):1-3

Associations between Thyroid Stimulating Hormone Levels and Both Severity and Early Outcome of Patients with Ischemic Stroke.

Delpont B, Aboa-Eboulé C, Durier J, Petit JM, Daumas A, Legris N, Daubail B, Giroud M, Béjot Y

Eur. Neurol.. 2016 ;76(3-4):125-131

Early cardiovascular events in women with a history of gestational diabetes mellitus.

Goueslard K, Cottenet J, Mariet AS, Giroud M, Cottin Y, Petit JM, Quantin C

Cardiovasc Diabetol. 2016 Jan;15:15

Liver fat content is negatively associated with atherosclerotic carotid plaque in type 2 diabetic patients.

Loffroy R, Terriat B, Jooste V, Robin I, Brindisi MC, Hillon P, Vergès B, Cercueil JP, Petit JM

Quant Imaging Med Surg. 2015 Dec;5(6):792-8

Insulin response dysregulation explains abnormal fat storage and increased risk of diabetes mellitus type 2 in Cohen Syndrome.

Limoge F, Faivre L, Gautier T, Petit JM, Gautier E, Masson D, Jego G, El Chehadeh-Djebbar S, Marle N, Carmignac V, Deckert V, Brindisi MC, Edery P, Ghoumid J, Blair E, Lagrost L, Thauvin-Robinet C, Duplomb L

Hum Mol Genet. 2015 Sep 10. pii: ddv366.

Intravoxel incoherent motion diffusion-weighted imaging in the liver: comparison of mono-, bi- and tri-exponential modelling at 3.0-T.

Cercueil JP, Petit JM, Nougaret S, Soyer P, Fohlen A, Pierredon-Foulongne MA, Schembri V, Delhom E, Schmidt S, Denys A, Aho S, Guiu B

Eur Radiol. 2015 Jun;25(6):1541-50

Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration.

Denimal D, Pais de Barros JP, Petit JM, Bouillet B, Verges B, Duvillard L

Atherosclerosis. 2015 Jun 29;241(2):752-760

GCKR polymorphism influences liver fat content in patients with type 2 diabetes.

Petit JM, Masson D, Guiu B, Rollot F, Duvillard L, Bouillet B, Brindisi MC, Buffier P, Hillon P, Cercueil JP, Verges B

Acta Diabetol. 2015 May 16.

Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis.

Petit JM, Pedro L, Guiu B, Duvillard L, Bouillet B, Jooste V, Habchi M, Crevisy E, Fourmont C, Buffier P, Hillon P, Cercueil JP, Verges B

Diabet Med. 2015 May 16

Glycated albumin with loss of fatty acid binding capacity contributes to enhanced arachidonate oxygenation and platelet hyperactivity: relevance in patients with type 2 diabetes.

Blache D, Bourdon E, Salloignon P, Lucchi G, Ducoroy P, Petit JM, Verges B, Lagrost L

Diabetes. 2015 Mar;64(3):960-72

Circulating apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control.

Habchi M, Duvillard L, Cottet V, Brindisi MC, Bouillet B, Beacco M, Crevisy E, Buffier P, Baillot-Rudoni S, Verges B, Petit JM

Clin Endocrinol (Oxf). 2014 Nov;81(5):696-701

No improvement of high-density lipoprotein (HDL) vasorelaxant effect despite increase in HDL cholesterol concentration in type 2 diabetic patients treated with glitazones.

Persegol L, Duvillard L, Monier S, Brindisi MC, Bouillet B, Petit JM, Verges B

J Clin Endocrinol Metab. 2014 Oct;99(10):E2015-9

Characteristics of diabetic patients and diabetes care in cardiac rehabilitation.

Beacco M, Verges-Patois B, Blonde MC, Crevisy E, Habchi M, Bouillet B, Buffier P, Petit JM, Verges B

Arch Cardiovasc Dis. 2014 Jun-Jul;107(6-7):391-7

3q27.3 microdeletional syndrome: a recognisable clinical entity associating dysmorphic features, marfanoid habitus, intellectual disability and psychosis with mood disorder.

Thevenon J, Callier P, Poquet H, Bache I, Menten B, Malan V, Cavaliere ML, Girod JP, Thauvin-Robinet C, El Chehadeh S, Pinoit JM, Huet F, Verges B, Petit JM, Mosca-Boidron AL, Marle N, Mugneret F, Masurel-Paulet A, Novelli A, Tumer Z, Loeys B, Lyonnet S, Faivre L

J Med Genet. 2014 Jan;51(1):21-7

A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.

Duvillard L, Ortega-Deballon P, Bourredjem A, Scherrer ML, Mantion G, Delhorme JB, Deguelte-Lardiere S, Petit JM, Bonithon-Kopp C

BMC Cancer. 2014 Dec 3;14:912

Body fat distribution and adipokine secretion are not associated with diabetic retinopathy in patients with type 2 diabetes mellitus.

Dossarps D, Petit JM, Guiu B, Cercueil JP, Duvillard L, Bron AM, Creuzot-Garcher C

Ophthalmic Res. 2014;51(1):42-5

Comparison of classification methods that combine clinical data and high-dimensional mass spectrometry data.

Truntzer C, Mostacci E, Jeannin A, Petit JM, Ducoroy P, Cardot H

BMC Bioinformatics. 2014 Nov 29;15:385

Preoperative adipocytokines as a predictor of surgical infection after colorectal surgery: a prospective survey.

Ortega-Deballon P, Duvillard L, Scherrer ML, Deguelte-Lardiere S, Bourredjem A, Petit JM, Bonithon-Kopp C

Int J Colorectal Dis. 2014 Jan;29(1):23-9

Pragmatic diabetes management in nursing homes: individual care plan.

Benetos A, Novella JL, Guerci B, Blickle JF, Boivin JM, Cuny P, Delemer B, Gabreau T, Jan P, Louis J, Passadori Y, Petit JM, Weryha G

J Am Med Dir Assoc. 2013 Nov;14(11):791-800

PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy.

Thauvin-Robinet C, Auclair M, Duplomb L, Caron-Debarle M, Avila M, St-Onge J, Le Merrer M, Le Luyer B, Heron D, Mathieu-Dramard M, Bitoun P, Petit JM, Odent S, Amiel J, Picot D, Carmignac V, Thevenon J, Callier P, Laville M, Reznik Y, Fagour C, Nunes ML, Capeau J, Lascols O, Huet F, Faivre L, Vigouroux C, Riviere JB

Am J Hum Genet. 2013 Jul 11;93(1):141-9

Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus.

Verges B, Guiu B, Cercueil JP, Duvillard L, Robin I, Buffier P, Bouillet B, Aho S, Brindisi MC, Petit JM

Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):3050-7

Liver fat content is associated with an increase in cholesterol synthesis independent of statin therapy use in patients with type 2 diabetes.

Brindisi MC, Guiu B, Duvillard L, Athias A, Rollot F, Bouillet B, Beacco M, Hillon P, Cercueil JP, Verges B, Petit JM

Atherosclerosis. 2012 Oct;224(2):465-8

Macroscopic heterogeneity of liver fat: an MR-based study in type-2 diabetic patients.

Capitan V, Petit JM, Aho S, Lefevre PH, Favelier S, Loffroy R, Hillon P, Krause D, Cercueil JP, Guiu B

Eur Radiol. 2012 Oct;22(10):2161-8

[Type 2 diabetes in the elderly, which specific features?].

Graillot D, Quipourt V, Bouillet B, Petit JM, Manckoundia P

Rev Med Interne. 2012 Oct;33(10):575-9

Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes.

Petit JM, Guiu B, Duvillard L, Jooste V, Brindisi MC, Athias A, Bouillet B, Habchi M, Cottet V, Gambert P, Hillon P, Cercueil JP, Verges B

Clin Nutr. 2012 Aug;31(4):520-5

Assessment of the use of hypolipidemic agents (HAs), mainly statins, in elderly subjects aged 80 years and more in Burgundy: analysis of 13,211 patients.

Manckoundia P, Lorenzini M, Disson-Dautriche A, Petit JM, Lorcerie B, Debost E, Menu D, Pfitzenmeyer P

Arch Gerontol Geriatr. 2012 Jul-Aug;55(1):101-5

Prediction for steatosis in type-2 diabetes: clinico-biological markers versus 1H-MR spectroscopy.

Guiu B, Crevisy-Girod E, Binquet C, Duvillard L, Masson D, Lepage C, Hamza S, Krause D, Verges B, Minello A, Cercueil JP, Hillon P, Petit JM

Eur Radiol. 2012 Apr;22(4):855-63

PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes.

Petit JM, Guiu B, Masson D, Duvillard L, Jooste V, Buffier P, Bouillet B, Brindisi MC, Robin I, Gambert P, Verges B, Cercueil JP, Hillon P

Liver Int. 2011 Oct;31(9):1332-6

Lack of an Association Between an Apolipoprotein C3 Genetic Variant and the Liver Fat Content in Patients with Type 2 Diabetes.

Petit JM, Guiu B, Masson D, Cercueil JP, Hillon P, Verges B

Hepatology. 2011 Sep 2;54(3):1109-10

Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.

Neuzillet Y, Tillou X, Mathieu R, Long JA, Gigante M, Paparel P, Poissonnier L, Baumert H, Escudier B, Lang H, Rioux-Leclercq N, Bigot P, Bernhard JC, Albiges L, Bastien L, Petit J, Saint F, Bruyere F, Boutin JM, Brichart N, Karam G, Branchereau J, Ferriere JM, Wallerand H, Barbet S, Elkentaoui H, Hubert J, Feuillu B, Theveniaud PE, Villers A, Zini L, Descazeaux A, Roupret M, Barrou B, Fehri K, Lebret T, Tostain J, Terrier JE, Terrier N, Martin L, Dugardin F, Galliot I, Staerman F, Azemar MD, Irani J, Tisserand B, Timsit MO, Sallusto F, Rischmann P, Guy L, Valeri A, Deruelle C, Azzouzi AR, Chautard D, Mejean A, Salomon L, Rigaud J, Pfister C, Soulie M, Kleinclauss F, Badet L, Patard JJ

Eur Urol. 2011 Aug;60(2):366-73

Endogenous chronic hyperinsulinemia does not increase the production rate of VLDL apolipoprotein B: proof from a kinetic study in patients with insulinoma.

Duvillard L, Florentin E, Pont F, Petit JM, Baillot-Rudoni S, Penfornis A, Verges B

J Clin Endocrinol Metab. 2011 Jul;96(7):2163-70

Low HDL-cholesterol: a strong predictor of glycemic response to glitazone treatment in patients with type 2 diabetes.

Verges B, Radu L, Baillot-Rudoni S, Brindisi MC, Poussier A, Bouillet B, Petit JM, Duvillard L

Diabetes Res Clin Pract. 2011 Jul;93(1):e44-8

The first case report of diaphragmatic paralysis as a paraneoplastic syndrome of medullary thyroid carcinoma.

Bouillet B, Petit JM, Tison LO, Beynat C, Brunot S, Baudoin N

. 2011 Jul;75(1):143-5.

Non-ultrasound-guided ethanol sclerotherapy for the treatment of thyroid cysts.

Verges B, Buffier P, Baillot-Rudoni S, Brindisi MC, Bouillet B, Petit JM

Ann Endocrinol (Paris). 2011 Jun;72(3):203-7

Liver methylene fraction by dual- and triple-echo gradient-echo imaging at 3.0T: Correlation with proton MR spectroscopy and estimation of robustness after SPIO administration.

Guiu B, Petit JM, Loffroy R, Aho S, Ben Salem D, Masson D, Robin I, Verges B, Hillon P, Cercueil JP, Krause D

J Magn Reson Imaging. 2011 Jan;33(1):119-27

Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents.

Ladoire S, Bonnetain F, Gauthier M, Zanetta S, Petit JM, Guiu S, Kermarrec I, Mourey E, Michel F, Krause D, Hillon P, Cormier L, Ghiringhelli F, Guiu B

Oncologist. 2011;16(1):71-81

Obesity, type 2 diabetes and risk of digestive cancer.

Hillon P, Guiu B, Vincent J, Petit JM

Gastroenterol Clin Biol. 2010 Oct;34(10):529-33.

Are elderly patients with diabetes being overtreated in French long-term-care homes?

Bouillet B, Vaillant G, Petit JM, Duclos M, Poussier A, Brindisi MC, Verges B

Diabetes Metab. 2010 Sep;36(4):272-7

Changes in apolipoprotein B100-containing lipoprotein metabolism due to an estrogen plus progestin oral contraceptive: a stable isotope kinetic study.

Duvillard L, Dautin G, Florentin E, Petit JM, Gambert P, Verges B

J Clin Endocrinol Metab. 2010 May;95(5):2140-6

Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer.

Guiu B, Petit JM, Bonnetain F, Ladoire S, Guiu S, Cercueil JP, Krause D, Hillon P, Borg C, Chauffert B, Ghiringhelli F

Gut. 2010 Mar;59(3):341-7

Response to anti-HCV therapy in HIV-HCV-coinfected patients: does the lipid profile really have an effect?

Petit JM, Carrat F, Duong M, Halfon P, Duvillard L, Bani-Sadr F, Chavanet P, Cacoub P, Piroth L

Antivir Ther. 2010;15(5):797-800.

Magnetic resonance imaging and spectroscopy for quantification of hepatic steatosis: urgent need for standardization!

Guiu B, Loffroy R, Hillon P, Petit JM

J Hepatol. 2009 Dec;51(6):1082-3; author reply 1083-4

[Fast technique to quantify liver steatosis at 3T: principles, parametric imaging and applications]

Guiu B, Loffroy R, Petit JM, Masson D, Hillon P, Cercueil JP, Krause D

J Radiol. 2009 Nov;90(11 Pt 1):1695-702.

[Magnetic resonance spectroscopy: a new standard for quantification of liver steatosis?]

Guiu B, Petit JM, Walker PM, Loffroy R, Hillon P, Brunotte F, Krause D, Cercueil JP

Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):967-70

Mapping of liver fat with triple-echo gradient echo imaging: validation against 3.0-T proton MR spectroscopy.

Guiu B, Loffroy R, Petit JM, Aho S, Ben Salem D, Masson D, Hillon P, Cercueil JP, Krause D

Eur Radiol. 2009 Jul;19(7):1786-93

Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.

Verges B, Florentin E, Baillot-Rudoni S, Petit JM, Brindisi MC, Pais de Barros JP, Lagrost L, Gambert P, Duvillard L

J Lipid Res. 2009 Jun;50(6):1209-15

[An aortic insufficiency diagnosed under cabergoline]

Chague F, Belleville I, Boujon B, Petit JM

Ann Cardiol Angeiol (Paris). 2009 Jun;58(3):189-91

A case of subacute thyroiditis associated with primary HIV infection.

Bouillet B, Petit JM, Piroth L, Duong M, Bourg JB

Am J Med. 2009 Apr;122(4):e5-6.

Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.

Guiu B, Petit JM, Loffroy R, Ben Salem D, Aho S, Masson D, Hillon P, Krause D, Cercueil JP

Radiology. 2009 Jan;250(1):95-102.

Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes.

Verges B, Florentin E, Baillot-Rudoni S, Monier S, Petit JM, Rageot D, Gambert P, Duvillard L

Diabetologia. 2008 Aug;51(8):1382-90

Distinct patterns of heparin affinity chromatography VLDL1 and VLDL2 subfractions in the different dyslipidaemias.

Duvillard L, Caslake MJ, Petit JM, Verges B, Gambert P, Packard CJ

Atherosclerosis. 2008 Jul;199(1):27-33

Aortic insufficiency under weak doses of cabergoline for non-tumoral hyperprolactinemia

Belleville I, Chague F, Petit JM, Boujon B

Ann Endocrinol (Paris). 2007 Dec;68(6):464-6

Liver steatosis and in-out of phase MR imaging: theory and clinical applications at 3T

Guiu B, Loffroy R, Ben Salem D, Masson D, Herve G, Petit JM, Krause D, Cercueil JP

J Radiol. 2007 Dec;88(12):1845-53.

No change in apolipoprotein AI metabolism when subcutaneous insulin infusion is replaced by intraperitoneal insulin infusion in type 1 diabetic patients.

Duvillard L, Florentin E, Baillot-Rudoni S, Lalanne-Mistrich ML, Brun-Pacaud A, Petit JM, Brun JM, Gambert P, Verges B

Atherosclerosis. 2007 Oct;194(2):342-7

Cell surface expression of LDL receptor in chronic hepatitis C: correlation with viral load.

Petit JM, Minello A, Duvillard L, Jooste V, Monier S, Texier V, Bour JB, Poussier A, Gambert P, Verges B, Hillon P

Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E416-20

An unusual complication of anticoagulation therapy in an elderly patient: Pituitary apoplexy with remission of acromegaly.

Audia S, Popitean L, Camus A, Pfitzenmeyer P, Petit JM

J Am Geriatr Soc. 2006 Nov;54(11):1798-800.

Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients.

Prunet C, Montange T, Vejux A, Laubriet A, Rohmer JF, Riedinger JM, Athias A, Lemaire-Ewing S, Neel D, Petit JM, Steinmetz E, Brenot R, Gambert P, Lizard G

Cytometry A. 2006 May;69(5):359-73.

Concentration of circulating oxidized LDL in HIV-infected patients treated with antiretroviral agents: relation to HIV-related lipodystrophy.

Duong M, Petit JM, Martha B, Galland F, Piroth L, Walldner A, Grappin M, Buisson M, Duvillard L, Chavanet P, Portier H

HIV Clin Trials. 2006 Mar-Apr;7(2):41-7.

Comparison of apolipoprotein B100 metabolism between continuous subcutaneous and intraperitoneal insulin therapy in type 1 diabetes.

Duvillard L, Florentin E, Baillot-Rudoni S, Lalanne-Mistrich ML, Brun-Pacaud A, Petit JM, Brun JM, Gambert P, Verges B

J Clin Endocrinol Metab. 2005 Oct;90(10):5761-4

[Study of ocular surface involvement in diabetic patients].

Creuzot-Garcher C, Lafontaine PO, Gualino O, D'Athis P, Petit JM, Bron A

J Fr Ophtalmol. 2005 Jun;28(6):583-8.

Pr PETIT Jean-Michel

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Projets

Publications

Retrouvez aussi